GlassScriptPhysician profile
Edwin W Maldonado
NPI 1184648362
$26,154.18
in general payments reported to CMS, 2019-2025
28 companies · $2,160 in 2025
The $2,160 reported for 2025 was more than what 80% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $2,211 · 2021: $17K · 2022: $1,700 · 2023: $925 · 2024: $1,707 · 2025: $2,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,791.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $17,884.65 | 2021-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $2,212.97 | 2020-2025 | Intracept, General - Pain Management, Superion Indirect Decompression System |
| Abbott Laboratories | $1,922.41 | 2019-2025 | Eterna, Octrode, Ionicrf |
| Vertos Medical, INC. | $1,421.21 | 2021-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $681.18 | 2019-2025 | Xtampza, Belbuca |
| Forte Bio-Pharma LLC | $300.58 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Valinor Pharma, LLC | $183.03 | 2023-2025 | Movantik |
| Interventional Pain Technologies INC. | $172.63 | 2021-2022 | |
| Medtronic, INC. | $153.88 | 2021-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Nalu Medical, INC. | $152.82 | 2022 | |
| Si-Bone, INC. | $145.42 | 2024 | |
| Protega Pharmaceutials INC | $120.86 | 2025 | Roxybond |
| Mml US, INC. | $106.51 | 2025 | Reactiv8 |
| Horizon Therapeutics Plc | $94.67 | 2019-2022 | |
| Globus Medical, INC. | $94.06 | 2025 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $92.45 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.59 | 2021-2025 | Relistor |
| Daiichi Sankyo INC. | $55.80 | 2019 | |
| Nevro Corp. | $55.24 | 2024 | Senza |
| Biotronik Nro, INC. | $44.22 | 2024 | Prospera |
| Kowa Pharmaceuticals America, INC. | $42.72 | 2022 | |
| Redhill Biopharma INC. | $40.95 | 2021-2022 | |
| Relievant Medsystems, INC. | $24.52 | 2021 | |
| Ibsa Pharma INC. | $21.48 | 2023 | Tirosint, Licart |
| Medtronic USA, INC. | $16.05 | 2020 | |
| Shockwave Medical, INC | $14.92 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sentynl Therapeutics, INC. | $13.55 | 2019 | |
| Electronic Waveform Lab, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Maldonado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.